Personal information

Activities

Employment (1)

The University of British Columbia: Vancouver, BC, CA

Professor (Urologic Sciences)
Employment
Source: Self-asserted source
Xuesen Dong

Education and qualifications (1)

University of Toronto: ON, ON, CA

2000 to 2005 | Ph.D. (Physiology)
Education
Source: Self-asserted source
Xuesen Dong

Works (12)

Developing novel Lin28 inhibitors by computer aided drug design

2024-10-14 | Preprint
Contributors: Xuesen Dong; Victor Barrios; Mariia Radaeva; Graciella Rosellinny; Qiongqiong Jia; Ning Xie; Jason Smith; Martin Gleave; Nada Lallous; Artem Cherkasov et al.
Source: check_circle
Crossref

Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer

Oncogene
2023-06-23 | Journal article
Contributors: Zhuoyuan Lin; Shivani Agarwal; Song Tan; Hongshun Shi; Xiaodong Lu; Zhipeng Tao; Xuesen Dong; Xu Wu; Jonathan C. Zhao; Jindan Yu
Source: check_circle
Crossref

TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer

Oncogene
2023-02-17 | Journal article
Contributors: Liancheng Fan; Yiming Gong; Yuman He; Wei-Qiang Gao; Xuesen Dong; Baijun Dong; Helen He Zhu; Wei Xue
Source: check_circle
Crossref

The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy

Pharmaceuticals
2023-01-09 | Journal article
Contributors: Victor M. Matias-Barrios; Xuesen Dong
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Discovery of Novel Lin28 Inhibitors to Suppress Cancer Cell Stemness

Cancers
2022-11-19 | Journal article
Contributors: Mariia Radaeva; Chia-Hao Ho; Ning Xie; Sijie Zhang; Joseph Lee; Liangliang Liu; Nada Lallous; Artem Cherkasov; Xuesen Dong
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Interferon signalling contributes to therapy‐resistant prostate cancer progression

Clinical and Translational Discovery
2022-09 | Journal article
Contributors: Amanda W. Dong; Artem Cherkasov; Xuesen Dong
Source: check_circle
Crossref

Lin28 Regulates Cancer Cell Stemness for Tumour Progression

Cancers
2022-09-24 | Journal article
Contributors: Zhuohui Lin; Mariia Radaeva; Artem Cherkasov; Xuesen Dong
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Methylation-dependent and -independent roles of EZH2 synergize in CDCA8 activation in prostate cancer

Oncogene
2022-03-10 | Journal article
Contributors: Yang Yi; Yanqiang Li; Chao Li; Longxiang Wu; Dongyu Zhao; Fuxi Li; Ladan Fazli; Rui Wang; Long Wang; Xuesen Dong et al.
Source: check_circle
Crossref

Optimization of New Catalytic Topoisomerase II Inhibitors as an Anti-Cancer Therapy

Cancers
2021-07-22 | Journal article
Contributors: Victor M. Matias-Barrios; Mariia Radaeva; Chia-Hao Ho; Joseph Lee; Hans Adomat; Nada Lallous; Artem Cherkasov; Xuesen Dong
Source: check_circle
Crossref

miR‐30a inhibits androgen‐independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4

The Prostate
2020-06 | Journal article
Contributors: Xinjun Li; Meng Jiao; Jing Hu; Mei Qi; Jing Zhang; Mingfeng Zhao; Hui Liu; Xueting Xiong; Xuesen Dong; Bo Han
Source: check_circle
Crossref

Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapy

Oncogene
2020-03-12 | Journal article
Contributors: Xuesen Dong; Ruiqi Chen
Source: check_circle
Crossref

SRRM4 gene expression correlates with neuroendocrine prostate cancer

The Prostate
2019-01 | Journal article
Contributors: Yinan Li; Qingfu Zhang; Jessica Lovnicki; Ruiqi Chen; Ladan Fazli; Yuzhuo Wang; Martin Gleave; Jiaoti Huang; Xuesen Dong
Source: check_circle
Crossref

Peer review (8 reviews for 3 publications/grants)

Review activity for Biology of reproduction. (3)
Review activity for British journal of cancer. (1)
Review activity for Oncogene. (4)